KARYOPHARM THERAPEUTICS INC - NOTE 3.000%10/1

Historical Portfolio Holders from Q4 2019 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Debt / NOTE 3.000%10/1
Principal, excl. options Q1 2024
145 M
Holdings value Q1 2024
$89.7 M
Value change Q1 2024
-$11.7 B
Grand Portfolio weight change Q1 2024
-0.025%
Number of holders
10
Number of buys Q1 2024
2
Number of sells Q1 2024
-3
Average buys Q1 2024 %
+0%
Average sells Q1 2024 %
-0.116%
CUSIP
48576UAA4
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Principal Value Change Price Investors
2024 Q1 $145 M $89.7 M -$11.7 B $0.54 10
2023 Q4 $165 M $83.3 M +$10.9 M $0.50 10
2023 Q3 $144 M $105 M $0 $0.64 10
2023 Q2 $136 M $105 M -$1.43 M $0.68 9
2023 Q1 $167 M $143 M +$337 K $0.77 10
2022 Q4 $157 M $129 M -$510 K $0.76 9
2022 Q3 $91.4 M $83.8 M -$1.74 M $0.81 8
2022 Q2 $101 M $78.8 M -$54.5 M $0.73 10
2022 Q1 $161 M $147 M +$2.01 M $0.84 17
2021 Q4 $148 M $133 M -$1.12 M $0.82 16
2021 Q3 $164 M $134 M -$2.6 M $0.75 17
2021 Q2 $164 M $179 M +$5.06 M $1.00 17
2021 Q1 $162 M $179 M -$13.6 M $1.04 13
2020 Q4 $179 M $224 M +$2.42 M $1.26 13
2020 Q3 $177 M $213 M -$7.31 M $1.20 13
2020 Q2 $180 M $254 M +$147 K $1.40 16
2020 Q1 $179 M $258 M -$1.67 M $1.44 14
2019 Q4 $180 M $258 M +$258 M $1.43 17